William McRae, MD
Interventional Pain Medicine · Dothan, ALNPI 1851421051
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Nevro Corp. at 25.4% of the total. Reporting peaked in 2019 at $418 and has fallen 89.8% since, to $43 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AL, where the typical reported total is $4,812.
Across 33 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$162
- Stimwave Technologies Incorporated$134
- Scilex Pharmaceuticals Inc.$65
- Vertex$60
- Boston Scientific$37
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$26
- plus $153 from 11 others
What the payments were for
- Food & beverage$638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 9 | $162 |
| Stimwave Technologies Incorporated | 2 | $134 |
| Scilex Pharmaceuticals Inc. | 4 | $65 |
| Vertex | 3 | $60 |
| Boston Scientific | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Si-bone, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
| B. Braun Medical Inc. | 1 | $13 |
| Pfizer | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
| Amgen | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Abbott | 1 | $11 |
How this compares
$638 in reported general payments places this provider in the 15th percentile of 33 interventional pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 424 | $7,823 |
| Lidocaine | 80 | $6,795 |
| Duloxetine Hcl | 369 | $6,025 |
| Gabapentin | 490 | $4,812 |
| Pregabalin | 235 | $3,174 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 111 | $2,201 |
| Naloxone Hcl | 19 | $1,330 |
| Methocarbamol | 126 | $1,009 |
| Baclofen | 114 | $779 |
| Tramadol Hcl | 99 | $579 |
| Tizanidine Hcl | 100 | $542 |
| Oxycodone Hcl | 12 | $422 |
| Etodolac | 13 | $405 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 52 | $404 |
| Amitriptyline Hcl | 22 | $394 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Dothan
- Mark WillisDothan$1K
- David EvansDothan$794
- Michael FlanaganDothan$563
- Michael KendrickBirmingham$90K
- Bradley WargoMuscle Shoals$41K
- Jacob VellaMontgomery$28K
- John IronsVestavia$22K
- Richard WebbFoley$18K
- Ryan AlmeidaBirmingham$14K
- Roberto ChangHoover$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.